Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

[Cardiovascular morbidity and mortality in renal diseases].

Kücükköylü S, Rump LC.

Dtsch Med Wochenschr. 2013 Apr;138(14):721-4. doi: 10.1055/s-0032-1332979. Epub 2013 Mar 26. Review. German. No abstract available.

PMID:
23533038
2.

Albuminuria and cardiovascular risk.

Bogojevic Z, Bakris GL.

Heart Fail Clin. 2006 Jan;2(1):53-9. Review. No abstract available.

PMID:
17386876
3.

[Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment].

Koziolek MJ, Bramlage CP, Vasko R, Grupp C, Müller GA.

Dtsch Med Wochenschr. 2009 Aug;134(34-35):1681-5. doi: 10.1055/s-0029-1234000. Epub 2009 Aug 25. Review. German.

PMID:
19707964
4.

Atrial fibrillation in end-stage renal disease.

Korantzopoulos P, Kokkoris S, Liu T, Protopsaltis I, Li G, Goudevenos JA.

Pacing Clin Electrophysiol. 2007 Nov;30(11):1391-7. Review.

PMID:
17976105
5.

Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.

McCullough PA, Verrill TA.

Postgrad Med. 2010 Mar;122(2):25-34. doi: 10.3810/pgm.2010.03.2119. Review.

PMID:
20203453
6.

Cardiorenal risk: an important clinical intersection.

McCullough PA.

Rev Cardiovasc Med. 2002 Spring;3(2):71-6. Review.

PMID:
12447150
7.

Outcomes in CKD: what we know and what we need to know.

Clark LE, Khan I.

Nephron Clin Pract. 2010;114(2):c95-102. doi: 10.1159/000254381. Epub 2009 Nov 3. Review.

8.

Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.

Bakris GL, Kuritzky L.

Postgrad Med. 2009 Jul;121(4):51-60. doi: 10.3810/pgm.2009.07.2031. Review.

PMID:
19641270
9.

Coronary revascularisation in chronic kidney disease. Part 1: stable coronary artery disease.

Seddon M, Curzen N.

J Ren Care. 2010 May;36 Suppl 1:106-17. doi: 10.1111/j.1755-6686.2010.00156.x. Review.

PMID:
20586906
10.

[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].

Ravera M, Paoletti E.

Ital Heart J Suppl. 2004 Jun;5(6):436-44. Review. Italian.

PMID:
15471148
11.

The importance of renin-angiotensin blockade in patients with cardio-renal disease.

Benavente D, Chue CD, Ferro CJ.

J Ren Care. 2010 May;36 Suppl 1:97-105. doi: 10.1111/j.1755-6686.2010.00166.x. Review.

PMID:
20586905
12.
13.

Renal disease: a common and a silent killer.

de Zeeuw D.

Nat Clin Pract Cardiovasc Med. 2008 Jul;5 Suppl 1:S27-35. doi: 10.1038/ncpcardio0853. Review.

PMID:
18580863
14.

Clinical epidemiology of cardiovascular disease in chronic kidney disease.

Foley RN.

J Ren Care. 2010 May;36 Suppl 1:4-8. doi: 10.1111/j.1755-6686.2010.00171.x. Review.

PMID:
20586894
15.

Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis.

Kaw R, Hernandez AV, Masood I, Gillinov AM, Saliba W, Blackstone EH.

J Thorac Cardiovasc Surg. 2011 May;141(5):1305-12. doi: 10.1016/j.jtcvs.2010.10.040. Epub 2011 Jan 17. Review.

16.

Targeting the renin angiotensin system in dialysis patients.

Cravedi P, Remuzzi G, Ruggenenti P.

Semin Dial. 2011 May-Jun;24(3):290-7. doi: 10.1111/j.1525-139X.2011.00939.x. Review.

PMID:
21682771
17.

The management of atrial fibrillation after cardiac surgery.

Rho RW.

Heart. 2009 Mar;95(5):422-9. doi: 10.1136/hrt.2007.132795. Review. No abstract available.

PMID:
19218267
18.

[Atrial fibrillation in dialysis patients].

Vázquez Ruiz de Castroviejo E, Sánchez Perales MC.

Nefrologia. 2006;26(1):16-24. Review. Spanish. No abstract available.

19.

Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.

Garcia-Donaire JA, Ruilope LM.

J Renin Angiotensin Aldosterone Syst. 2006 Mar;7(1):56-8. Review. No abstract available.

PMID:
17083074
20.

Current treatments of atrial fibrillation.

Marmont PR, Gooszen M.

J La State Med Soc. 1999 May;151(5):257-64. Review.

PMID:
10363480

Supplemental Content

Support Center